Efficacy and safety of glycoprotein IIb/IIIa receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis.
type: Dataset
contact point: Organization
  fn: CCSD
keyword: mesh-humans
keyword: mesh-middle-aged
keyword: mesh-female
keyword: mesh-thrombolytic-therapy
keyword: mesh-male
keyword: infoeu-reposemanticsarticle
keyword: mesh-kaplan-meier-estimate
keyword: mesh-risk-assessment
keyword: mesh-odds-ratio
keyword: mesh-chi-square-distribution
keyword: mesh-france
keyword: mesh-aged
keyword: mesh-time-factors
keyword: mesh-registries
keyword: mesh-logistic-models
keyword: mesh-hemorrhage
keyword: mesh-stroke
keyword: mesh-platelet-glycoprotein-gpiib-iiia-complex
keyword: journal-articles
keyword: mesh-myocardial-infarction
keyword: mesh-recurrence
keyword: mesh-platelet-aggregation-inhibitors
keyword: mesh-hospital-mortality
keyword: mesh-coronary-angiography
keyword: mesh-patient-selection
keyword: mesh-risk-factors
keyword: mesh-treatment-outcome
keyword: mesh-propensity-score
keyword: mesh-drug-administration-schedule
keyword: sdvspeelife-sciences-q-biosante-publique-et-epidemiologie
keyword: mesh-angioplasty-balloon-coronary
landing page: 1522-1946
description: International audience
issued: 2026-05-10T09:37:08.059263
language: en
modified: 2026-05-10T09:37:08.059268

Efficacy and safety of glycoprotein IIb/IIIa receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis.
type: Distribution
access URL: https://hal.science/hal-00843437
format: HTML
issued: 2026-05-10T09:37:08.097724
modified: 2026-05-10T09:37:08.030775

test_moissonnage_selune
type: Agent